Ekso Indego Personal to be Featured on ‘Health Uncensored’ with Dr. Drew Pinsky - Seite 2
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation,
statements regarding (i) the potential benefits of Ekso Indego, (ii) the performance or effectiveness of the Company’s products, including the Ekso Indego, (iii) the potential impacts to patients
from using the Company’s products, (iv) the assumptions underlying or relating to any statement described in clauses (i) through (iii) above and (v) the expected appearance by the Company on
‘Health Uncensored’ and the timing thereof. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and may not be realized
because they are based upon the Company’s current projections, plans, objectives, beliefs, expectations, estimates and assumptions and are subject to a number of risks and uncertainties and other
influences, many of which the Company has no control over. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking
statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially
from expected or desired results may include, without limitation, patient, or therapist dissatisfaction with Ekso Indego, risks related to product liability, recall and warranty claims, and
adjustments to the television scheduling. These and other factors are identified and described in more detail in the Company’s filings with the U.S. Securities and Exchange Commission. To learn
more about Ekso Bionics please visit the Company’s website at www.eksobionics.com or follow @EksoBionics on X. The Company does not undertake to update these forward-looking statements.
Lesen Sie auch
Contacts:
Investors:
David Carey
FINN Partners
212-867-1768
investors@eksobionics.com